Big Money Negative on Colgate Palmolive Co (NYSE:CL), Sentiment at 0.87

May 16, 2018 - By Palma Niemeyer

Positions for Colgate Palmolive Co (NYSE:CL)

In Q4 2017 Colgate Palmolive Co (NYSE:CL) big money sentiment decreased to 0.87, SEC filings reveal. That’s down -0.03, from 2017Q3’s 0.9. 433 institutional investors increased and opened new holdings, while 500 sold and decreased equity positions in Colgate Palmolive Co so the sentiment has dropped. Funds own 606.34 million shares, down from 617.24 million shares in 2017Q3. Funds holding Colgate Palmolive Co in top 10 changed to 16 from 22 for a decrease of 6. In total 56 funds closed positions, 444 reduced and 335 increased. Also 98 funds bought new Colgate Palmolive Co stakes.

Biggest Colgate Palmolive Co Shareholders

Vgi Partners Pty Ltd owns 833,921 shares in Colgate Palmolive Co as of Q4 2017. Colgate Palmolive Co’s shareholder Ycg Llc owns 470,688 shares as of Q4 2017. Bush Odonnell Investment Advisors Inc reported 96,198 shares. Bank Pictet & Cie (Asia) Ltd revealed 172,354 shares position in Colgate Palmolive Co. The Massachusetts-based fund East Coast Asset Management Llc. holds 243,754 shares or 5.01% of their US long equity exposure.

Colgate-Palmolive Company, together with its subsidiaries, makes and sells consumer products worldwide.The firm is worth $54.16 billion. It operates through two divisions, Oral, Personal and Home Care; and Pet Nutrition.26.32 is the P/E ratio. The firm offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, bleaches, and other related products.

CL is reaching $62.09 during the last trading session, after increased 0.71%.Colgate-Palmolive Company has volume of 3.76 million shares. Since May 16, 2017 CL has declined 5.65% and is downtrending. CL underperformed by 17.20% the S&P 500.

On July, 20 Colgate-Palmolive Company (NYSE:CL)’s earnings release is awaited by WallStreet, RTT reports. Last year’s EPS was $0.72, while now analysts expect change of 9.72 % up from current $0.79 EPS. If the current EPS of $0.79 is accurate, CL’s profit could reach $689.13M. 6.76 % EPS growth is what Wall Street’s predicts after $0.74 reported EPS previous quarter.

19,608 are owned by Carret Asset Lc. Macquarie Group Limited holds 11,800 shs. Ballentine Prtnrs Limited Liability Company reported 6,833 shs stake. Abner Herrman And Brock Limited Liability Com owns 25,161 shs or 0.32% of their US capital. Provident Investment Management owns 11,858 shs. Assetmark accumulated 4,244 shs. Cognios Cap Limited Liability Corporation has invested 0.77% of its capital in Colgate-Palmolive Company (NYSE:CL). Willingdon Wealth holds 0.77% or 31,047 shs. Amf Pensionsforsakring Ab, a Sweden-based fund reported 953,699 shs. 585,070 were reported by Btim Corporation. Cwm Limited Company holds 4,069 shs. Utd Capital Fincl Advisers Llc has 0.28% invested in Colgate-Palmolive Company (NYSE:CL). Advantus Mngmt reported 0.17% of its capital in Colgate-Palmolive Company (NYSE:CL). Thompson Rubinstein Invest Incorporated Or reported 60,831 shs stake. Provise Management Gp Ltd reported 0.17% in Colgate-Palmolive Company (NYSE:CL).

Colgate-Palmolive Company registered $32.94 million net activity with 0 buys and 20 insider sales since December 13, 2017. Skala Justin also sold $292,026 worth of Colgate-Palmolive Company (NYSE:CL) shs. Daniels Jennifer sold 902 shs worth $68,390. Shares for $396,561 were sold by HICKEY DENNIS J. Wallace Noel R. also sold $321,701 worth of Colgate-Palmolive Company (NYSE:CL) shs. On Friday, February 9 HUSTON JOHN J had sold 14,000 shs worth $972,125. Another trade for 1,572 shs valued at $110,310 was made by Verduin Patricia on Tuesday, February 20.

Colgate-Palmolive Company (NYSE:CL) Ratings Coverage

Total analysts of 10 have positions in Colgate-Palmolive (NYSE:CL) as follows: 1 rated it a “Buy”, 1 with “Sell” and 8 with “Hold”. The positive are 10%. Since November 22, 2017 according to StockzIntelligence Inc Colgate-Palmolive has 12 analyst reports. On Wednesday, November 29 the rating was downgraded by Societe Generale to “Sell”. On Wednesday, November 22 the rating was maintained by KeyBanc Capital Markets with “Hold”. The stock rating was maintained by Citigroup with “Neutral” on Tuesday, May 1. On Tuesday, January 30 Citigroup maintained the shares of CL in report with “Neutral” rating. On Tuesday, December 19 the company was upgraded by Macquarie Research. On Monday, April 30 the stock of Colgate-Palmolive Company (NYSE:CL) has “Hold” rating given by Morgan Stanley. On Thursday, January 4 Jefferies maintained Colgate-Palmolive Company (NYSE:CL) with “Hold” rating. On Friday, April 20 Morgan Stanley maintained Colgate-Palmolive Company (NYSE:CL) with “Overweight” rating. In Tuesday, April 17 report Stifel Nicolaus maintained the stock with “Hold” rating.

More recent Colgate-Palmolive Company (NYSE:CL) news were released by Seekingalpha.com, Seekingalpha.com and Benzinga.com. The first one has “Colgate-Palmolive: A Consumer Defensive Heavyweight” as a title and was released on May 14, 2018. The next is “Retirement Strategy: I Am Done Being Wrong About This Market” on May 16, 2018. And last was released on April 30, 2018, called “Morgan Stanley Shifts To Neutral On Colgate-Palmolive, Cites Emerging Markets Weakness”.

Colgate-Palmolive Company (NYSE:CL) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.